Glen Short

Title: Glen Short: Innovator in Pharmaceutical Compositions

Introduction

Glen Short is a notable inventor based in Scituate, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions involving N—N-dimethyltryptamine (DMT). His work focuses on innovative methods of treatment for various disorders.

Latest Patents

Glen Short holds a patent for "N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereof." This patent describes pharmaceutical compositions that include an amorphous N—N-dimethyltryptamine (DMT) or a pharmaceutically acceptable salt or prodrug thereof, along with a polymeric carrier. These compositions are designed for buccal or sublingual administration to patients. The patent also outlines methods for treating disorders, including neurological disorders, through the administration of these compositions.

Career Highlights

Glen Short is currently associated with Atai Therapeutics Inc., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various neurological conditions, showcasing his commitment to innovation in the pharmaceutical industry.

Collaborations

Glen collaborates with esteemed colleagues such as Srinivas G Rao and Majed Fawaz, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Glen Short's contributions to pharmaceutical compositions and his innovative approaches to treatment highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical therapies.